Document Classification

Section Type: RESULTS

Text: Otherwise, there were no significant differences in time for ventilatory support (Duraflo II, 1. 7 + / - 1. 3 hours ; Carmeda BioActive Surface, 1. 6 + / - 1. 0 hours ; P =. 37), amount of postoperative mediastinal drainage (Duraflo II, 665 + / - 257 mL ; Carmeda BioActive Surface, 688 + / - 243 mL ; P =. 07), need for allogeneic blood-plasma transfusions (Duraflo II, 4. 2 % of the patients ; Carmeda BioActive Surface, 4. 4 % of the patients ; P =. 93), or hemoglobin concentration at hospital discharge (Duraflo II, 120 + / - 13 g/L ; Carmeda BioActive Surface, 119 + / - 13 g/L ; P =. 08).